292 related articles for article (PubMed ID: 17659568)
21. MRI appearances of borderline ovarian tumours.
Bent CL; Sahdev A; Rockall AG; Singh N; Sohaib SA; Reznek RH
Clin Radiol; 2009 Apr; 64(4):430-8. PubMed ID: 19264189
[TBL] [Abstract][Full Text] [Related]
22. The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option.
Booth SJ; Turnbull LW; Poole DR; Richmond I
BJOG; 2008 Jun; 115(7):894-901. PubMed ID: 18485169
[TBL] [Abstract][Full Text] [Related]
23. Ovarian mucinous cystadenoma of borderline malignancy in a premenarchal girl.
Iwasaki M; Taira K; Kobayashi H; Saiga T
J Pediatr Adolesc Gynecol; 2010 Jun; 23(3):e119-23. PubMed ID: 19896401
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of cystic ovarian lesions using apparent diffusion coefficient calculated from turboFLASH MR images.
Moteki T; Ishizaka H
Br J Radiol; 1998 Jun; 71(846):612-20. PubMed ID: 9849383
[TBL] [Abstract][Full Text] [Related]
25. Incidentally detected lesions on contrast-enhanced MR imaging in candidates for breast-conserving therapy: correlation between MR findings and histological diagnosis.
Yabuuchi H; Kuroiwa T; Kusumoto C; Fukuya T; Ohno S; Hachitanda Y
J Magn Reson Imaging; 2006 Apr; 23(4):486-92. PubMed ID: 16521096
[TBL] [Abstract][Full Text] [Related]
26. Management of borderline ovarian tumors.
Tîrnovanu MC; Amancei S; Dumitrescu A; Onofriescu M; Dumitraşcu I
Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1069-75. PubMed ID: 23700890
[TBL] [Abstract][Full Text] [Related]
27. Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha/GLUT-1 expression.
Iida T; Yasuda M; Miyazawa M; Fujita M; Osamura RY; Hirasawa T; Muramatsu T; Murakami M; Saito K; Mikami M
Arch Gynecol Obstet; 2008 Jun; 277(6):539-46. PubMed ID: 18026974
[TBL] [Abstract][Full Text] [Related]
28. Overview of the clinical problem: facts and current issues of mucinous cystic neoplasms of the pancreas.
Jeurnink SM; Vleggaar FP; Siersema PD
Dig Liver Dis; 2008 Nov; 40(11):837-46. PubMed ID: 18499541
[TBL] [Abstract][Full Text] [Related]
29. Primary and metastatic mucinous adenocarcinomas of the ovary: Evaluation of the diagnostic approach using tumor size and laterality.
Khunamornpong S; Suprasert P; Pojchamarnwiputh S; Na Chiangmai W; Settakorn J; Siriaunkgul S
Gynecol Oncol; 2006 Apr; 101(1):152-7. PubMed ID: 16300822
[TBL] [Abstract][Full Text] [Related]
30. Diversity in size and signal intensity in multilocular cystic ovarian masses: new parameters for distinguishing metastatic from primary mucinous ovarian neoplasms.
Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Saida T; Yoshikawa H; Minami M
J Magn Reson Imaging; 2013 Oct; 38(4):794-801. PubMed ID: 23440747
[TBL] [Abstract][Full Text] [Related]
31. [Cystic mucinous pulmonary tumor of borderline malignancy. Report of a case].
Pelletier B; Dubigeon P; Despins P; De Lajartre AY
Ann Pathol; 1993; 13(6):405-8. PubMed ID: 8141933
[TBL] [Abstract][Full Text] [Related]
32. Primary retroperitoneal mucinous tumors: a clinicopathologic study of 18 cases.
Roma AA; Malpica A
Am J Surg Pathol; 2009 Apr; 33(4):526-33. PubMed ID: 19092632
[TBL] [Abstract][Full Text] [Related]
33. Expression of c-myc and mutation of the KRAS gene in patients with ovarian mucinous tumors.
Li XS; Sun J; He XL
Genet Mol Res; 2015 Sep; 14(3):10752-9. PubMed ID: 26400304
[TBL] [Abstract][Full Text] [Related]
34. Ovarian mucinous borderline tumors of intestinal type without intraepithelial carcinoma: are they still tumors of low malignant potential?
Nomura K; Aizawa S; Hano H
Pathol Int; 2004 Jun; 54(6):420-4. PubMed ID: 15144401
[TBL] [Abstract][Full Text] [Related]
35. [Clinical-pathological relationships of potenially malignant cystadenomas of the ovaries].
Gáti E; Töttössy B; Sugár J
Zentralbl Gynakol; 1978; 100(15):978-84. PubMed ID: 706881
[TBL] [Abstract][Full Text] [Related]
36. Mucinous cystic tumor of the retroperitoneum. A report of two cases.
Motoyama T; Chida T; Fujiwara T; Watanabe H
Acta Cytol; 1994; 38(2):261-6. PubMed ID: 8147222
[TBL] [Abstract][Full Text] [Related]
37. Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.
Brun JL; Cortez A; Commo F; Uzan S; Rouzier R; Daraï E
Int J Oncol; 2008 Dec; 33(6):1239-46. PubMed ID: 19020757
[TBL] [Abstract][Full Text] [Related]
38. Sarcoma-like mural nodule in an ovarian mucinous cystadenoma: a case report.
Agarwal K; Meenakshi ; Agarwal C; Jain K
Indian J Pathol Microbiol; 2004 Apr; 47(2):226-8. PubMed ID: 16295477
[TBL] [Abstract][Full Text] [Related]
39. Ovarian vessel dilatation with ovarian mass on MR images: influence of pelvic venous plexus dilatation.
Matsumoto S; Kaji Y; Manabe T; Kitamura Y; Hirata Y; Sugimura K
Radiat Med; 2004; 22(5):296-302. PubMed ID: 15553009
[TBL] [Abstract][Full Text] [Related]
40. Management of suspected pancreatic cystic neoplasms based on cyst size.
Walsh RM; Vogt DP; Henderson JM; Hirose K; Mason T; Bencsath K; Hammel J; Brown N
Surgery; 2008 Oct; 144(4):677-84; discussion 684-5. PubMed ID: 18847654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
